Cell-cell interactions mediating primary and metastatic breast cancer dormancy
Nicholas A Lenart1, Shreyas S Rao2
1Department of Chemical and Biological Engineering, The University of Alabama, Tuscaloosa, AL, 35487-0203, USA.
Cancer Metastasis Reviews
|November 25, 2024
Summary
Breast cancer cell dormancy at primary and metastatic sites is influenced by the tumor microenvironment. Understanding these cell-cell interactions is crucial for developing new breast cancer treatments.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Breast cancer is a leading cause of death in women globally.
- Metastasis, driven by dormant cancer cells, accounts for most breast cancer deaths.
- Mechanisms regulating cancer cell dormancy and proliferation are not fully understood.
Purpose of the Study:
- To review the role of cell-cell interactions within the tumor microenvironment in mediating breast cancer dormancy.
- To highlight how various immune and stromal cells impact breast cancer cell dormancy versus proliferation.
- To emphasize the need for advanced model systems to study these interactions.
Main Methods:
- Review of existing literature on breast cancer dormancy and the tumor microenvironment.
- Analysis of cell-cell interactions involving lymphoid cells, myeloid cells, and stromal cells.
- Discussion of mechanisms underlying dormancy regulation.
Main Results:
- Tumor microenvironment components, including immune and stromal cells, significantly influence breast cancer cell dormancy.
- Specific cell types and their interactions mediate the switch between dormant and proliferative states.
- Understanding these interactions is key to targeting dormant breast cancer cells.
Conclusions:
- Cell-cell interactions within the tumor microenvironment are critical regulators of breast cancer dormancy.
- Targeting these interactions holds therapeutic potential for preventing metastasis and recurrence.
- Further research using sophisticated models is essential to elucidate these complex mechanisms.
Related Concept Videos
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


